【摘要】 目的观察消臌软坚丸对肝硬化大鼠肝组织病理学和表皮生长因子(EGF)的影响。方法采用四氯化碳复合因素造模法复制肝硬化大鼠模型,随机分组处理:正常组和模型组灌服生理盐水,消臌软坚丸低、高剂量组每日分别灌胃消臌软坚丸混悬液1.6g/kg体重和3.2g/kg体重,阳性药对照组每日灌胃复方鳖甲软肝片混悬液0.6g/kg体重,共4周。光镜下观察肝硬化大鼠肝组织病理形态学变化;并测定血清和肝组织EGF含量。结果与正常组比较,模型组大鼠肝间质广泛纤维组织增生,将正常肝小叶分割成大小不等的肝细胞团(即假小叶形成),血清和肝组织EGF含量明显升高(P<0.01)。与模型组比较,消臌软坚丸高、低剂量组和阳性药对照组肝小叶结构亦受损,少量纤维组织增生,但未见形成间隔。血清和肝组织EGF含量明显下降(P<0.05或P<0.01)。其中高剂量组与阳性药对照组比较差异有统计学意义(P<0.05)。结论消臌软坚丸能显著改善肝硬化大鼠的肝脏病理组织学损害,同时可降低血清和肝组织EGF水平,具有显著的抗肝脏纤维化、阻断肝硬化进程的作用,对腹水的产生与消退也产生积极的影响。更多还原

【Abstract】 Objective To observe the effect of Xiaogu Ruanjian pills on hepatic histopathology and epidermal growth factor (EGF) of liver cirrhosis rats. Methods The rats model of cirrhosis was made by complex factors,compared with Fufang Biejia Ruanganpian,the effect of Xiaogu Ruanjian Pills on hepatic pathology and EGF were observed. Results Compared with the normal group,extensive fibrous tissue hyperplasia can be seen in hepatic mesenchyme of the model group,the liver pseudolobule formed,and the contents of EGF in serum and liver were increased (P <0.01). Compared with the model group,there were a few fibrous tissue hyperplasia in high-dosage group,low-dosage group and control group,no fibrotic septa formed,and he contents of EGF in serum and liver were decreased (P<0.01 or P <0.05). There was significant difference between high-dosage group and control group (P<0.05). Conclusion Xiaogu Ruanjian pills can obviously improve the cirrhosis rat pathology,decrease the contents of EGF in serum and liver,decrease or restrain the happening or development of ascites.更多还原